WeVote
Log In

Bill

Bill

HR 3731

Small Biotech Innovation Act

119th Congress Introduced by David Kustoff and 3 co-sponsors

The Small Biotech Innovation Act boosts small biotech firms by providing funding, easing regulations, and fostering partnerships, enhancing innovation and patient care.

Introduced in House
0
WeVote Research Nonpartisan
Bill Summary · HR 3731

Summary of HR 3731 - Small Biotech Innovation Act

Bill Overview

Bill Number: HR 3731
Title: Small Biotech Innovation Act
Status: Introduced in House
Introduced On: June 04, 2025
Classification: Bill

Purpose and Intent

The Small Biotech Innovation Act aims to foster growth and innovation within the small biotechnology sector. The bill seeks to provide targeted support for small biotech companies, which are crucial for advancing medical research and developing new therapies. By enhancing funding opportunities and streamlining regulatory processes, the bill intends to stimulate investment in biotechnology research and development.

Key Provisions

While the specific text of the bill is not provided, the following key provisions are typically expected in legislation of this nature:

  • Funding Support: The bill may propose grants or tax incentives to encourage investment in small biotech firms.
  • Regulatory Relief: It could include measures to simplify the approval process for new biotech products, making it easier for small companies to bring innovations to market.
  • Collaboration Opportunities: The legislation may promote partnerships between small biotech firms and larger pharmaceutical companies or research institutions to enhance resource sharing and innovation.

Affected Parties

The Small Biotech Innovation Act is expected to impact several stakeholders, including:

  • Small Biotechnology Companies: These firms will benefit from increased funding and reduced regulatory burdens, enabling them to innovate more effectively.
  • Investors: The bill may attract more investment into the biotech sector, as financial incentives could lower the risk associated with funding small companies.
  • Patients and Healthcare Providers: By facilitating the development of new therapies, the bill aims to improve healthcare outcomes and expand treatment options for patients.

Legislative Process

  • Introduced: The bill was introduced in the House on June 04, 2025.
  • Committee Referral: It has been referred to the Committee on Energy and Commerce and the Committee on Ways and Means for consideration. The Speaker will determine the period for review by these committees.

Related Legislation

  • S 1930: This bill has a companion in the Senate, which may provide additional support and momentum for its passage.

Conclusion

The Small Biotech Innovation Act represents a significant effort to bolster the small biotech sector, which plays a vital role in medical advancements. By providing financial support and easing regulatory challenges, the bill aims to enhance innovation and ultimately improve patient care. As it moves through the legislative process, stakeholders will be closely monitoring its progress and potential impact on the biotechnology landscape.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.